Bon Natural Life Ltd Net Assets
Bon Natural Life Ltd net assets. Based on the latest financial reports, Bon Natural Life Ltd (BON) has net assets worth $58.00 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($85.19 Million) and total liabilities ($27.19 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore BON net assets growth trend to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $58.00 Million |
| % of Total Assets | 68.08% |
| Annual Growth Rate | 43.86% |
| 5-Year Change | 118.57% |
| 10-Year Change | N/A |
| Growth Volatility | 40.82 |
Net Assets of Bon Natural Life Ltd (2018–2025)
Net assets of Bon Natural Life Ltd from 2018 to 2025. This chart illustrates how Bon Natural Life Ltd's net assets have evolved over time, based on quarterly financial data. See BON equity to assets ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Bon Natural Life Ltd (2018–2025)
The table below shows the annual net assets of Bon Natural Life Ltd from 2018 to 2025. For live market cap and overall valuation, see Bon Natural Life Ltd (BON) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $58.00 Million | +30.77% |
| 2024-09-30 | $44.35 Million | +23.26% |
| 2023-09-30 | $35.98 Million | +19.57% |
| 2022-09-30 | $30.09 Million | +13.41% |
| 2021-09-30 | $26.53 Million | +140.72% |
| 2020-09-30 | $11.02 Million | +51.76% |
| 2019-09-30 | $7.26 Million | +59.76% |
| 2018-09-30 | $4.55 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bon Natural Life Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 31810.0% over the analyzed period, indicating profitable operations and earnings retention.
Bon Natural Life Ltd Net Assets Breakdown (September 2025)
Bon Natural Life Ltd net assets breakdown by equity component as of September 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $16.63 Million | 28.90% |
| Common Stock | $154.22K | 0.27% |
| Other Comprehensive Income | $-26.13K | -0.05% |
| Other Components | $40.79 Million | 70.88% |
| Total Equity | $57.55 Million | 100.00% |
Bon Natural Life Ltd Competitors by Market Cap
The table below lists competitors of Bon Natural Life Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BioLight Life Sciences Ltd
TA:BOLT
|
$6.89 Million |
|
Safello Group AB
ST:SFL
|
$6.89 Million |
|
NEVADA LITHIUM RESOURCES
F:87K
|
$6.89 Million |
|
Quantum Helium Limited
LSE:QHE
|
$6.89 Million |
|
Fly Play hf.
IC:PLAY
|
$6.88 Million |
|
JPMorgan European Growth & Income plc
LSE:JEGI
|
$6.88 Million |
|
Data Storage Corp
NASDAQ:DTST
|
$6.87 Million |
|
JW Pharmaceutical Corp
KO:001067
|
$6.87 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bon Natural Life Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 43,906,691 to 57,550,680, a change of 13,643,989 (31.1%).
- Net loss of 1,994,768 reduced equity.
- New share issuances of 10,672,912 increased equity.
- Other comprehensive income decreased equity by 182,067.
- Other factors increased equity by 5,147,912.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.99 Million | -3.47% |
| Share Issuances | $10.67 Million | +18.55% |
| Other Comprehensive Income | $-182.07K | -0.32% |
| Other Changes | $5.15 Million | +8.95% |
| Total Change | $- | 31.07% |
Book Value vs Market Value Analysis
This analysis compares Bon Natural Life Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.05x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-09-30 | $8.80 | $1.13 | x |
| 2019-09-30 | $13.24 | $1.13 | x |
| 2020-09-30 | $20.18 | $1.13 | x |
| 2021-09-30 | $38.78 | $1.13 | x |
| 2022-09-30 | $35.21 | $1.13 | x |
| 2023-09-30 | $38.58 | $1.13 | x |
| 2024-09-30 | $18.27 | $1.13 | x |
| 2025-09-30 | $20.89 | $1.13 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bon Natural Life Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.47%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -10.68%
- • Asset Turnover: 0.22x
- • Equity Multiplier: 1.48x
- Recent ROE (-3.47%) is below the historical average (15.06%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 4.91% | 2.07% | 0.65x | 3.66x | $-231.27K |
| 2019 | 37.64% | 15.70% | 0.84x | 2.86x | $1.89 Million |
| 2020 | 28.78% | 16.61% | 0.72x | 2.40x | $1.98 Million |
| 2021 | 17.65% | 18.01% | 0.70x | 1.40x | $1.99 Million |
| 2022 | 21.10% | 20.86% | 0.80x | 1.26x | $3.28 Million |
| 2023 | 12.95% | 15.57% | 0.63x | 1.31x | $1.05 Million |
| 2024 | 0.91% | 1.67% | 0.39x | 1.41x | $-3.99 Million |
| 2025 | -3.47% | -10.68% | 0.22x | 1.48x | $-7.75 Million |
Industry Comparison
This section compares Bon Natural Life Ltd's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $1,264,155,492
- Average return on equity (ROE) among peers: -3.99%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bon Natural Life Ltd (BON) | $58.00 Million | 4.91% | 0.47x | $6.88 Million |
| Albemarle Corp (ALB) | $622.60 Million | 12.56% | 0.93x | $10.64 Billion |
| Alto Ingredients Inc (ALTO) | $392.81 Million | -0.04% | 0.16x | $275.36 Million |
| Aemetis Inc (AMTX) | $-9.45 Million | 0.00% | 0.00x | $83.00 Million |
| Air Products and Chemicals Inc (APD) | $4.73 Billion | 15.06% | 1.20x | $62.29 Billion |
| Ashland Global Holdings Inc (ASH) | $3.41 Billion | 0.03% | 1.53x | $3.34 Billion |
| ASP Isotopes Inc. Common Stock (ASPI) | $18.83 Million | -86.49% | 0.60x | $277.49 Million |
| Aspen Aerogels Inc (ASPN) | $128.41 Million | -21.71% | 0.42x | $407.47 Million |
| Avient Corp (AVNT) | $631.40 Million | 11.39% | 2.37x | $3.38 Billion |
| Axalta Coating Systems Ltd (AXTA) | $2.39 Billion | 15.80% | 2.18x | $7.02 Billion |
| Balchem Corporation (BCPC) | $331.36 Million | 13.54% | 0.14x | $5.17 Billion |
About Bon Natural Life Ltd
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and … Read more